Eduardo Tschen

3.3k citations

48 papers · 2.1k indexed · h-index 22

Impact in

Dermatology top 0.2%
- Dermatology and Skin Diseases
- Dermatologic Treatments and Research
- Cutaneous lymphoproliferative disorders research
- Skin Protection and Aging
- Acne and Rosacea Treatments and Effects
Urology top 2%
- Hair Growth and Disorders

Papers in

Dermatology 31
- Dermatology and Skin Diseases 13
- Acne and Rosacea Treatments and Effects 11
- Skin Protection and Aging 4
Immunology and Allergy 7
- Allergic Rhinitis and Sensitization 6
- Food Allergy and Anaphylaxis Research 4

Co-authors: John E. Wolf Elise A. Olsen David M. Pariser Joseph R. Taylor Frank Dunlap Ronald J. Trancik James M. Swinehart Carol L. Kulp‐Shorten
Journals: Journal of the American Academy of Dermatology (15 papers)Advances in Therapy (2 papers)The Journal of Immunology (2 papers)Journal of Investigative Dermatology (1 paper)Pediatric Dermatology (1 paper)
Partner nations: United States Switzerland Belgium

In The Last Decade

Eduardo Tschen

48 papers receiving 2.0k citations

Peers

Countries citing papers authored by Eduardo Tschen

Since Specialization

Citations

This map shows the geographic impact of Eduardo Tschen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Tschen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Tschen more than expected).

Fields of papers citing papers by Eduardo Tschen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Tschen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Tschen. The network helps show where Eduardo Tschen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eduardo Tschen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eduardo Tschen Line = papers co-authored together Eduardo Tschen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis Journal of the American Academy of Dermatology ·Lawrence F. Eichenfield, Robert S. Call, Douglass W. Forsha, Joseph F. Fowler, Adelaide A. Hebert, Mary Spellman, Linda Stein Gold, ChengXu Cao, Lee T. Zane, Eduardo Tschen	2017	109
2	Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open‐Label, Maximal‐Use Systemic Exposure Study Pediatric Dermatology ·Lee T. Zane, Leon Kircik, Robert S. Call, Eduardo Tschen, Zoé Kececioglu Draelos, Sanjay Chanda, ChengXu Cao, Adelaide A. Hebert	2016	61
3	280 Long-term safety of crisaborole topical ointment, 2%, in atopic dermatitis Journal of Investigative Dermatology ·Lawrence F. Eichenfield, Robert S. Call, Douglass W. Forsha, Joseph F. Fowler, Adelaide A. Hebert, Mary Spellman, Linda Stein Gold, ChengXu Cao, Lee T. Zane, Eduardo Tschen	2016	1
4	Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis Journal of the American Academy of Dermatology ·Lawrence L. Anderson, George Schmieder, Wm. Philip Werschler, Eduardo Tschen, Mark Ling, Dow B. Stough, Matt Etlinger	2009	101
5	Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up British Journal of Dermatology ·Eduardo Tschen, David S.Y. Wong, David M. Pariser, Tosporn Kasikam, MR. BALARAM SAHU, Mary Beth Ferdon, (unknown)	2006	114
6	Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma. PubMed ·Helen Torok, Terry M. Jones, Phoebe Rich, Stacy Smith, Eduardo Tschen	2005	61
7	A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis Journal of the American Academy of Dermatology ·Steven Kempers, Mark Boguniewicz, Eric Carter, Michael Jarratt, David M. Pariser, L. Parravicini, Guillaume Thiery, Eduardo Tschen, 康原田, L. Su, Beatrice Abrams	2004	88
8	A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men Journal of the American Academy of Dermatology ·Elise A. Olsen, Frank Dunlap, Tilman May, Suci Yandhini, James M. Swinehart, Eduardo Tschen, Ronald J. Trancik	2002	271
9	Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses International Journal of Dermatology ·John E. Wolf, Joseph R. Taylor, Eduardo Tschen, 植田剛司	2001	161
10	Efficacy and safety of terbinafine for nondermatophyte and mixed nondermatophyte and dermatophyte toenail onychomycosis International Journal of Dermatology ·Mark Lebwohl, C. Ralph Daniel, William D. James, Zack Ravetz, Joel S. Shavin, Eduardo Tschen, Jonathan M. Weiss, John J. Zone	2001	22
11	Assessment of HPA-Axis Suppression with Fluticasone Cream 0.05% in Patients with Extensive Psoriasis or Eczema Clinical Drug Investigation ·Eduardo Tschen, A Bucko	1998	5
12	Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail Journal of the American Academy of Dermatology ·Phoebe Rich, Richard K. Scher, Debra Breneman, R Savin, Y.H.Chen, Nellie Konnikov, Jerome L. Shupack, Sheldon R. Pinnell, Norman Levine, Nicholas J. Lowe, Raza Aly, Richard B. Odom, Donald L. Greer, 石井善輝, A Bucko, Eduardo Tschen, Boni E. Elewski, Edgar B. Smith, James Hilbert	1998	31
13	Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect Journal of the American Academy of Dermatology ·Gerald D. Weinstein, Gerald G. Krueger, Nicholas J. Lowe, Madeleine Duvic, David J. Friedman, Brian V. Jegasothy, Joseph L. Jorizzo, Edward Shmunes, Eduardo Tschen, Deborah A. Lew‐Kaya, John Lue, John Sefton, John R. Gibson, 吕青林	1997	131
14	Efficacy of terbinafine 1% cream in the treatment of moccasin-type tinea pedis: Results of placebo-controlled multicenter trials Journal of the American Academy of Dermatology ·Ronald Savin, Immaculada Ponsa Arjona, Paul R. Bergstresser, 英男岡部, Henry E. Jones, H Ho Thai, William D. James, Y.A. Titov, Amit G. Pandya, Jerome L. Shupack, Matthew J. Stiller, Eduardo Tschen, Fernando LÓPEZ-MORALES, Nardo Zaias, Jay E. Birnbaum	1994	20
15	Topical terbinafine and clotrimazole in interdigital tinea pedis: A multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens Journal of the American Academy of Dermatology ·Paul R. Bergstresser, 英男岡部, Jon M. Hanifin, Jack L. Lesher, Ronald Savin, Jerome L. Shupack, Matthew J. Stiller, Eduardo Tschen, Nardo Zaias, Jay E. Birnbaum	1993	53
16	Efficacy of a 1-week, twice-daily regimen of terbinafine 1 % cream in the treatment of interdigital tinea pedis Journal of the American Academy of Dermatology ·Brian Berman, Charles N. Ellis, William D. James, Nicholas J. Lowe, Ronald Savin, Jerome L. Shupack, Matthew J. Stiller, Eduardo Tschen, Nardo Zaias, Jay E. Birnbaum	1992	55
17	Comparison of skin changes induced on mice by either group A type 12 or group G streptococci Experimental Dermatology ·Els Descendents, E. M. Macdonald, Eduardo Tschen, Danny G. Thomas, 王先明	1992	1
18	A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck Journal of the American Academy of Dermatology ·Elise A. Olsen, M. Lisa Abernethy, Carol L. Kulp‐Shorten, Jeffrey P. Callen, Scott D. Glazer, Arthur C. Huntley, Michael K. McCray, Y.A. Titov, Eduardo Tschen, John E. Wolf	1991	303
19	Topical tioconazole in tinea pedis Advances in Therapy ·Gong Yun-zha, Linda‐Gail Bekker, Eduardo Tschen, Gabriel Dos Reis Santos Cunha, J. Derrick	1988	5
20	Treatment of interdigital tinea pedis and tinea (pityriasis) versicolor with bifonazole 1% solution applied once daily Advances in Therapy ·Gong Yun-zha, Eduardo Tschen	1986	4

About Eduardo Tschen

Eduardo Tschen is a scholar working on Dermatology, Immunology and Allergy, Epidemiology, Cell Biology and Periodontics, having authored 48 papers that have together received 2.1k indexed citations. Recurring topics across this work include Nail Diseases and Treatments (18 papers), Dermatology and Skin Diseases (13 papers), Acne and Rosacea Treatments and Effects (11 papers), Allergic Rhinitis and Sensitization (6 papers), Nonmelanoma Skin Cancer Studies (6 papers), Plant Pathogens and Fungal Diseases (6 papers), Food Allergy and Anaphylaxis Research (4 papers) and Skin Protection and Aging (4 papers). The work is most often cited by research in Dermatology (1.4k citations), Urology (264 citations), Immunology and Allergy (237 citations), Cell Biology (448 citations) and Epidemiology (901 citations). Eduardo Tschen has collaborated with scholars based in United States, Switzerland and Belgium. Frequent co-authors include John E. Wolf, Elise A. Olsen, David M. Pariser, Joseph R. Taylor, Frank Dunlap, Ronald J. Trancik, James M. Swinehart, Carol L. Kulp‐Shorten, Michael K. McCray and Scott D. Glazer. Their work appears in journals such as Journal of the American Academy of Dermatology, Advances in Therapy, The Journal of Immunology, Journal of Investigative Dermatology and Pediatric Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact